Genetic basis for the cooperative bioactivation of plant lignans by Eggerthella lenta and other human gut bacteria

Nature Microbiology

Volumn 5, Issue 1, 2020, Pages 56-66

  Bess, Elizabeth N ^a,b   Bisanz, Jordan E ^a   Yarza, Fauna ^a   Bustion, Annamarie ^a   Rich, Barry E ^b   Li, Xingnan ^c   Kitamura, Seiya ^d   Waligurski, Emily ^a   Ang, Qi Yan ^a   Alba, Diana L ^e   Spanogiannopoulos, Peter ^a   Nayfach, Stephen ^f   Koliwad, Suneil K ^e   Wolan, Dennis W ^d   Franke, Adrian A ^c   Turnbaugh, Peter J ^a,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f DOE JOINT GENOME INSTITUTE   (United States)

^g CHAN ZUCKERBERG BIOHUB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYL ETHER REDUCTASE; LIGNAN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN;

BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BER GENE; BIOTRANSFORMATION; CORIOBACTERIIA; EGGERTHELLA LENTA; GENE IDENTIFICATION; GENE LOCUS; GENOMICS; GNOTOBIOTICS; GRAM POSITIVE BACTERIUM; INTESTINE FLORA; LETTER; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; RNA SEQUENCE; UPREGULATION; ACTINOBACTERIA; ANIMAL; BACTERIAL GENOME; CHEMISTRY; CLASSIFICATION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METABOLISM; MICROBIAL CONSORTIUM; MOUSE; SPECIES DIFFERENCE;

ACTINOBACTERIA; ANIMALS; BACTERIAL PROTEINS; BIOTRANSFORMATION; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION PROFILING; GENOME, BACTERIAL; HUMANS; LIGNANS; METABOLIC NETWORKS AND PATHWAYS; MICE; MICROBIAL CONSORTIA; PHYLOGENY; SPECIES SPECIFICITY;

EID: 85074776384     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/s41564-019-0596-1     Document Type: Letter

References (45)

1. Adlercreutz, H. Lignans and human health. Crit. Rev. Clin. Lab. Sci. 44, 483–525 (2007).
2. Clavel, T., Doré, J. & Blaut, M. Bioavailability of lignans in human subjects. Nutr. Res. Rev. 19, 187–196 (2006).
3. Spanogiannopoulos, P., Bess, E. N., Carmody, R. N. & Turnbaugh, P. J. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat. Rev. Microbiol. 14, 273–287 (2016).
4. Carmody, R. N. & Turnbaugh, P. J. Host–microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J. Clin. Invest. 124, 4173–4181 (2014).
5. Koppel, N., Maini Rekdal, V. & Balskus, E. P. Chemical transformation of xenobiotics by the human gut microbiota. Science 356, eaag2770 (2017).
6. Valsta, L. M. et al. Phyto-oestrogen database of foods and average intake in Finland. Br. J. Nutr. 89, S31–S38 (2011).
7. Woting, A., Clavel, T., Loh, G. & Blaut, M. Bacterial transformation of dietary lignans in gnotobiotic rats. FEMS Microbiol. Ecol. 72, 507–514 (2010).
8. Clavel, T. & Mapesa, J. O. in Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes (eds Ramawat, K. G. & Mérillon, J.-M.) 2433–2463 (Springer, 2013).
9. Olsen, A. et al. Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidemiol. Biomarkers Prev. 13, 2084–2089 (2004).
10. Sonestedt, E. et al. Enterolactone is differently associated with estrogen receptor β-negative and -positive breast cancer in a Swedish nested case-control study. Cancer Epidemiol. Biomarkers Prev. 17, 3241–3251 (2008).
11. Seibold, P. et al. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis. Int. J. Cancer 135, 923–933 (2014).
12. Mabrok, H. B. et al. Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis 33, 203–208 (2012).
13. Saarinen, N. M. et al. Enterolactone inhibits the growth of 7,12-dimethylbenz(a) anthracene-induced mammary carcinomas in the rat. Mol. Cancer Ther. 1, 869–876 (2002).
14. Zaineddin, A. K. et al. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status. Int. J. Cancer 130, 1401–1410 (2012).
15. Stitch, S. R. et al. Excretion, isolation and structure of a new phenolic constituent of female urine. Nature 287, 738–740 (1980).
16. Setchell, K. D. R. et al. Lignans in man and in animal species. Nature 287, 740–742 (1980).
17. Clavel, T. et al. Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl. Environ. Microbiol. 71, 6077–6085 (2005).
18. Clavel, T., Borrmann, D., Braune, A., Doré, J. & Blaut, M. Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. Anaerobe 12, 140–147 (2006).
19. Wang, L.-Q., Meselhy, M. R., Li, Y., Qin, G.-W. & Hattori, M. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Chem. Pharm. Bull. 48, 1606–1610 (2000).
20. Clavel, T., Henderson, G., Engst, W., Doré, J. & Blaut, M. Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol. Ecol. 55, 471–478 (2006).
21. Bisanz, J. E. et al. Illuminating the microbiome’s dark matter: a functional genomic toolkit for the study of human gut Actinobacteria. Preprint at https://www.biorxiv.org/content/10.1101/304840v1 (2018).
22. Haiser, H. J. et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341, 295–298 (2013).
23. Koppel, N., Bisanz, J. E., Pandelia, M.-E., Turnbaugh, P. J. & Balskus, E. P. Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins. eLife 7, e33953 (2018).
24. Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J. & Balskus, E. P. Discovery and inhibition of an interspecies gut bacterial pathway for levodopa metabolism. Science 364, eaau6323 (2019).
25. Davis, R. M., Muller, R. Y. & Haynes, K. A. Can the natural diversity of quorum-sensing advance synthetic biology? Front. Bioeng. Biotechnol. 3, 30 (2015).
26. Rohman, A., van Oosterwijk, N., Thunnissen, A.-M. W. H. & Dijkstra, B. W. Crystal structure and site-directed mutagenesis of 3-ketosteroid Δ1-dehydrogenase from Rhodococcus erythropolis SQ1 explain its catalytic mechanism. J. Biol. Chem. 288, 35559–35568 (2013).
27. Fukuhara, Y. et al. Discovery of pinoresinol reductase genes in sphingomonads. Enzyme Microb. Technol. 52, 38–43 (2013).
28. Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628 (2018).
29. Milder, I. E. J. et al. Intake of the plant lignans secoisolariciresinol, matairesinol, lariciresinol, and pinoresinol in Dutch men and women. J. Nutr. 135, 1202–1207 (2005).
30. Matthews, R. G. Cobalamin- and corrinoid-dependent enzymes. Met. Ions Life Sci. 6, 53–114 (2009).
31. Hille, R. The molybdenum oxotransferases and related enzymes. Dalton Trans. J. Inorg. Chem. 42, 3029–3042 (2013).
32. Nayfach, S., Fischbach, M. A. & Pollard, K. S. MetaQuery: a web server for rapid annotation and quantitative analysis of specific genes in the human gut microbiome. Bioinformatics 31, 3368–3370 (2015).
33. Nayfach, S., Shi, Z. J., Seshadri, R., Pollard, K. S. & Kyrpides, N. C. New insights from uncultivated genomes of the global human gut microbiome. Nature 568, 505–510 (2019).
34. Alba, D. L. et al. Subcutaneous fat fibrosis links obesity to insulin resistance in Chinese-Americans. J. Clin. Endocrinol. Metab. 103, 3194–3204 (2018).
35. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
36. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
37. Anders, S., Pyl, P. T. & Huber, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).
38. Tang, H. & Mayersohn, M. Porcine prediction of pharmacokinetic parameters in people: a pig in a poke? Drug Metab. Dispos. 46, 1712–1724 (2018).
39. Bolvig, A. K., Adlercreutz, H., Theil, P. K., Jørgensen, H. & Bach Knudsen, K. E. Absorption of plant lignans from cereals in an experimental pig model. Br. J. Nutr. 115, 1711–1720 (2016).
40. Gohl, D. M. et al. Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies. Nat. Biotechnol. 34, 942–949 (2016).
41. Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).
42. Franke, A. A. et al. Liquid chromatographic–photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J. Chromatogr. B 777, 45–59 (2002).
43. Franke, A. A., Halm, B. M., Kakazu, K., Li, X. & Custer, L. J. Phytoestrogenic isoflavonoids in epidemiologic and clinical research. Drug Test. Anal. 1, 14–21 (2009).
44. Begum, A. N. et al. Dietary lignins are precursors of mammalian lignans in rats. J. Nutr. 134, 120–127 (2004).
45. Yu, G., Smith, D. K., Zhu, H., Guan, Y. & Lam, T. T.-Y. ggtree: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. 8, 28–36 (2017).